Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The Whelans and Dr Staelin owning most of the convertible notes is exactly why I am optimistic about a BIEL Turnaround.
The only way they get their loans repaid is with a profitable BIEL and a rising SP.
There is no market for converted shares with BIEL trading in the triple zeros.
Speaking of SofPulse, they joined BIEL on 'Pink Limited' status last week
<<<<<<< Hope he doesn't wait for the SofPulse trial to finish and publish them together. >>>>>>>
ENDV, the current owner of SofPulse, purchased the SofPulse patents, already FDA Cleared, 6 years ago for $4.5 million . Neither of their own research projects, Immunotronics and Cytotronics, have ever been FDA Cleared.
With a current Market Cap of $1.065 million the ENDV CEO is trying to spin off SofPulse into its own company. They are looking for an analyst that will value the new company at $50-100 million.
ENDV has been trying to purchase a concrete company for several years. That is correct, a medical device company was trying to buy a concrete company. Big surprise, that 'deal' fell through.
ENDV's SP is currently at .0032, this after a 1 for 1,000 Reverse Split 4 years ago. If you had one million shares of ENDV before the RS you now have one thousand shares. To compare ENDV to BIEL, which has no RS, you can add 3 zeros (to the right of the decimal point) back into their current SP, which equals .0000032 .
To the 'Usual Suspects' that claim BIEL is a scam, Allan Collier CEO of ENDV would say, Hold my beer and I will show you what a real scam looks like.
You're one of the handful of desperate Bashers here trying to convince shareholders to sell their shares
Been predicting the end of BIEL at every downturn for the last 12 years, always wrong.
28,113 posts and nothing to show for it.
Notice the handful of very small trades at .0001 to desperately try to hold the price down
Over 24 million shares traded today and only 32k were at .0001 .
Over 400 million shares on the Bid at .0001 today and no one wants to sell.
Just sayin.
LOL, excited by a 32k share trade at 1 worth $3
>>>>>>> this may be it <<<<<<<
"During the first second quarter of 2018, the Company entered into a convertible note agreement with
James Eason, receiving financing of $135,000, with an interest rate of 8% per annum and convertible
at a rate of $.0003 per share. This loan and related interest was converted into 629,856,000 shares of
common stock in July 2020" - From the EOY 2020 Financials
In Q2 2018 BIEL's SP ranged between .001 and .005 .
"The conversion prices on the convertible notes payable have generally been 50% or less of the pink
sheet closing price of the common stock on the date the notes or advances are issued to reflect the
restricted nature of the stock into which the notes could be converted and the Board of Directors’
belief that the closing stock price is not reflective of the fair market value of the common stock due
to the price volatility, and lack of an active market for trading shares resulting in limited trading
volume of share transactions. The Board of Directors is active in negotiating conversion prices for
each issuance and takes into consideration all information in establishing the issuance date fair market
value"
LOL, 6 million Buys to 762k Sells
Go peddle your BS elsewhere.
This website does have a 2024 copyright
" Wayan Srl copyright © 2024 | P. IVA: 02747970909 0.4195 "
https://www.fogliettoillustrativo.net/listino_prodotti/601E/pharmatech-srl?p=1
You have been corrected on this false statement before, yet you keep repeating it
<<<<< 50% discounted priced stock upon their note/loan maturities, when all other stockholders have to pay full price for their shares >>>>>
Your BFF JimmyZ, a BIEL shareholder, got his $135k loan repaid on 7/27/2020 with 629 million, 50% discounted shares. this is documented in BIEL's Financials.
Simpsonly made a post confirming his convertible loan to BIEL and stated anyone who wanted to do the same should give AW a call.
The interest, fees, and terms on any loan are determined by the risk involved. Loaning money to a Pink Sheet company is considered high risk. Pink Sheets need to offer a large reward for taking that risk to attract lenders. Looking at the Financials will show that many of BIEL's lenders are not family members.
Thanks Hawk, that is quite the list of RecoveryRx/ActiPatch products
It appears that BIEL has some new irons in the fire.
"Pharmatech has an outstanding experience in the design, construction and validation of any size or type of project in the Pharmaceutical, Biotechnology and Healthcare fields."
"We offer a complete range of services for any type of Pharma facility, covering the following activities: Consultancy (GMP audit/GAMP analysis, Project URS preparation, Assistance to Site Selection, Site Master Planning, Feasibility Study, Conceptual Design, Process Simulation – Construction Management) Engineering & Construction (Basic Design, Detailed Engineering, Project Management, Project Control, Procurement, Construction Management) Handover (Commissioning, Qualification/Validation, Start-up & training)."
Summary of the product's characteristics
Product Name: recoveryrx post-op kit l 12cm
Manufacturer: pharmatech srl
Product Category: Sanitary Instruments
Product Type: Medical Device
Product Class: 2
AIC code: 924752583
This product has no Aifa notes
Source: https://www.fogliettoillustrativo.net/bugiardino/recoveryrx-kit-post-op-l-12cm-924752583
RECOVERYRX POST-OP KIT L 12CM
Category: Healthcare Instruments (Other), Healthcare Instruments
Type: Medical Device Manufactured by: pharmatech srl
Source: https://www.fogliettoillustrativo.net/listino_prodotti/601E/pharmatech-srl?p=1
RECOVERYRX POST-OP KIT S 8CM
Category: Healthcare Instruments (Other), Healthcare Instruments
Type: Medical Device Manufactured by: pharmatech srl
Source: https://www.fogliettoillustrativo.net/listino_prodotti/601E/pharmatech-srl?p=1
RECOVERYRX ACUTE PAIN KIT
Category: Healthcare Instruments (Other), Healthcare Instruments
Type: Medical Device Manufactured by: pharmatech srl
Source: https://www.fogliettoillustrativo.net/listino_prodotti/601E/pharmatech-srl?p=1
RECOVERYRX BACK KIT
Category: Healthcare Instruments (Other), Healthcare Instruments
Type: Medical Device Manufactured by: pharmatech srl
Source: https://www.fogliettoillustrativo.net/listino_prodotti/601E/pharmatech-srl?p=1
RECOVERYRX KNEE KIT
Category: Healthcare Instruments (Other), Healthcare Instruments
Type: Medical Device Manufactured by: pharmatech srl
Source: https://www.fogliettoillustrativo.net/listino_prodotti/601E/pharmatech-srl?p=1
ALLAY MENSTRUAL PAIN KIT
Category: Healthcare Instruments (Other), Healthcare Instruments
Type: Medical Device Manufactured by: pharmatech srl
Source: https://www.fogliettoillustrativo.net/listino_prodotti/601E/pharmatech-srl?p=1
SMART INSOLE BEAD KIT 1PCS
Category: Healthcare Instruments (Other), Healthcare Instruments
Type: Medical Device Manufactured by: pharmatech srl
Source: https://www.fogliettoillustrativo.net/listino_prodotti/601E/pharmatech-srl?p=1
BIEL's latest CE Mark covers both ActiPatch and RecoveryRx for OTC Sales.
The board's 'Liar-in-Chief' spreading another Load of Manure
This pitiful soul was terminated by BIEL and has spent the last 12 years trying to destroy the company as revenge.
There is a scam artist at work here but it is not BIEL.
The scammer is ddls who stops at nothing, including quoting a nonexistent company, 'Sales Track', to achieve his goal.
Scam companies do not hold 5 FDA Clearances for treating medical conditions.
The FDA says that BIEL's products are effective at reducing pain.
A glaring problem with your KW Bash
<<<<<< since nobody proofreads Whelan's work >>>>>>
KW did not prepare the 2019, 2020, 2021, 2022 EOY financial reports, Brian Flood did. KW signed a statement saying:
"Based on my knowledge, the financial statements, and other financial information included or
incorporated by reference in this disclosure statement, fairly present in all material respects the financial
condition, results of operations and cash flows of the issuer as of, and for, the periods presented in this
disclosure statement."
B. The following financial statements were prepared by (name of individual):
Name: Brian Flood
Title: Consultant
Relationship to Issuer: Consultant
Accountant or Auditor
Name: Brian Flood
Firm: Consult Your CFO
Address 1: 1680 Nickerson Way
Address 2: Arnold, MD 21012
Phone: 443-838-6352
Email: floodbp@gmail.com
Good Grief, No one with a functioning brain believes that there is currently a market for billions of new BIEL shares
KW, PW and RS have a zero chance of getting their loans paid back unless they pull off a major company turnaround.
With millions of dollars at stake the Whelans and Dr Staelin are doing everything possible to breath new life into BIEL.
A Profitable BIEL benefits both lenders and shareholders.
Sales-Track shows that the poster is a habitual liar willing to say anything to inflict damage on BIEL
BIEL fired ddls, with cause, 14 years ago and he has been trying to destroy the company ever since.
Every year same story, "BIEL is doomed", "BK coming any day now", same BS repeated over and over, always wrong.
96 percent efficacy is very rare in a study, nice to see Dr Sree Koneru consulting with BIEL again
https://onlinelibrary.wiley.com/doi/10.1002/vms3.1408
Holding pattern until EOY statement and company Update
3/31 is a Sunday so financials due 4/1 . Update could come before or after financials.
Enjoy.
Wrong again, 1.1 million shares bought at 3 today out of a 1.7 million share total Buy volume
<<<<<<<<< those .0002's became BUYS >>>>>>>>>>
Sells had a whopping 202k shares, 142k of those shares were Sells at 2 . Only 60k shares sold at 1 .
Forgot to mention only 60k shares actually sold at .0001
Buys over Sells 8 to 1 .
LOL, not a good look when your #1 cheerleader is the admitted liar, ddls
But I am confident it will be considered "Fun".
Zero selling so far today with no news is a positive outcome for Longs.
I am sure those who want BIEL to fail are unhappy with Dr Staelin's support for BIEL.
"Staelin is not foregoing interest on his loans, and it's accruing." Sounds like you are acknowledging there was "foregoing interest" by the Whelans, as the BIEL PR stated, why don't you tell your buddy Art. As far as Staelin earning interest on his loans, it is a debt owed that BIEL currently has no means to pay back. Give KW a call I am sure she can give you the same terms.
"I don't know what interest rate he's charging now, but his loans charge a rate that's considerably higher than the fixed rates at the time of loan inception. Take his January 2022 loan, for example: it appears to be accruing at about 8% interest -- back when CD's were paying around a half a percent." Trying to compare a CD interest rate to the loan rate of a high risk OTC Pink Sheet company is a classic Apples to Oranges comparison . Loan interest rates increase with the level of risk.In January 2022 my Chase credit card would have charged me 14.99% if did not pay the full balance on the card, Capital One would have been 17.9%. BIEL is getting a great deal, with 8% and no possibility of conversion/dilution, given their financial state. I would bet that they would give that same deal to any shareholder who wanted to loan them money.
"Kind of a sweet deal Staelin has going, unless, of course, BIEL can never repay him." That is the point, the $2 plus million that Sttaelin has loaned, the $3.6 million that PW has loaned, the $6 million plus that KW has loaned may never be paid back.
"CD's have been paying over 5% for several months. I'll wager that Staelin's rate has also increased considerably." I would say he has probably kept it at 8%. We will find out in 2 weeks along with how many new loans he has made to BIEL through the end of 2023 to keep BIEL solvent.
As I suspected, won't touch Art's $2.5 million interest BS
A true classic in Art's long list of disinformation.
Come on, give it a spin, this would be "Fun" to watch.
LOL, Sounds like you are now the Official Spinner for Bonehead Basher Posts
However, that does advance the theory that bashers are organized. Say hello to Simpson for me.
You did miss Art's $2.5 million interest BS. Was that one too far in the weeds for even you to touch?
LOL, BIEL shares information on manufacturing changes with shareholders and somebody finds a reason to complain about it, must be hanging out with Art.
Some on this board have complained about BIEL not sharing enough information with shareholders. Thank you for sharing this manufacturing information Dr Staelin.
The circuitry is "already sealed in an epoxy bubble" but the on/off button is not. It has a protective film covering it but I have found devices with corrosion under the film that stops a device from turning on while it still has 2.8 volts coming off the battery. That would be my guess on the "reliability" issue. I believe BIEL calls ActiPatch 'Water Resistant' not 'Water Proof'. Maybe they found a way to make it 'Water Proof' for heavy sweaters and those into water sports. Give Biel a call if it's troubling you.
As far as the "Shelf Life", it could be a better quality battery, or something else. Give BIEL a call if it's troubling you.
No one can be this obtuse, deliberately trying to deceive/confuse board members is the alternative.
I have corrected you before on this issue, BIEL does Not Pay Interest on convertible loans on a Quarterly or Annual basis, interest is added to the loan amount, all convertible loans are currently being 'rolled over' due to the AS ceiling.
<<<<<<<<< no ---- MONEY ------ to ----- pay ----- $2.5 MILLION >>>>>>>>>>
BIEL has not converted any loans since 1/25/2022 and that conversion to St John's was made so that PW could make several new loans to BIEL.
The foregoing of $2.5 million in interest lowers BIEL's loan debts by $2.5 million, period. That is a positive event for all shareholders.
You will try to minimize it because you do not want BIEL to succeed.
Same old low comprehension Art
<<<<<<<<< Where is this company going to get $2.5 MILLION to pay that interest >>>>>>>>>>
The Whelans 'gave up' that $2.5 million in interest to lower BIEL's debts. As in it is erased and will never have to be paid.
"Forego - If you forego something, you choose to give it up. If you forego dessert after dinner, you are skipping dessert. The verb forego (also spelled forgo) literally means “to go by.” In common usage it means “to abstain” or “do without.” You might forego smoking cigarettes as a New Year's resolution."
I would say those 1,677 followers are listening Along with 'The Whale' and his 3,328 followers
<<<<<<<< No one is listening to you >>>>>>>>
Thanks Hawk, Onex provides a very useful service
"Onex is a medical marketplace that connects manufacturer, distributors, and end-users globally, by providing manufacturers and distributors online exposure and marketing. We sell medical products from suppliers to buyers in bulk quantities worldwide. We also sell matching services where we assign distributors to medical manufacturers worldwide."
Dr Staelin has made 20 Non-Convertible Loans, $860k, to BIEL since he returned to the COB position in 2020
The Whelans have foregone $2.5 million in loan interest.
BIEL spent money recently redesigning the ActiPatch to increase reliability and shelf life.
This is not the typical run up to a "pump and dump".
MM Shorting worse than yesterday, 98.5% Naked Shorting, MMs only ones selling
FINRA Daily Short Report
Date ..... Symbol . Short vol .. Total vol
20240313 | BIEL | 27970000 | 28380721
What a hot steamy load of BS
<<<<<<<<<<<< They're winding down due to no money >>>>>>>>>>>>
The 2/15/2024 Update from Dr Staelin states that BIEL has recently upgraded the ActiPatch for greater reliability and shelf life. BIEL wouldn't spend money upgrading ActiPatch if they were "winding down". The "Ugly" thing here is that you lie on a daily basis. Exact quote from the Update below.
"The Company, working with its Chinese manufacturer, recently redesigned the manufacturing process to increase the reliability and shelf life of its current OTC product. The Company also did a proof-of-concept production run of its newly designed RecoveryRx product that is 50% more powerful and has a larger antenna thereby increasing the size of the surgical incision that can be treated. The plan is to test market these devices in the near future."
https://finance.yahoo.com/news/bioelectronics-chairman-updates-investors-140000529.html
FINRA Facts, Only 2 million shares were sold today by an actual shareholder
20.5 million shares were shorted by MMs today, did not own them and did not borrow them.
FINRA Daily Short Report
Date .... Symbol .. Short vol ... Total vol
20240312 | BIEL| 20550000 | 22671483
I listed several facts regarding how KT chose to market the Wave
KT's marketing of the Wave, or the lack thereof, severely impacted BIEL and BIEL's Shareholders. BIEL is the one that revoked KT's exclusive rights in the US and it was the correct decision because KT did not deliver the minimum sales results that the contract required.
I could have easily added more adjectives to describe KT's mishandling of the Wave but I did not.
Reading the BIEL Board daily I am exposed to copious amounts of bashing. Pointing out why KT lost their exclusive contract is not bashing.
* KT is an athlete brand ranging from professional to weekend warrior, younger demographic
* Actipatch has a customer base consisting largely of chronic pain patients, older demographic
* KT never marketed the Wave to chronic pain patients, a market which is many times larger than the athlete market
* KT priced the Wave at $34.95, $5 more than ActiPatch, and lowered the life to 250 hours, 470 hours less than ActiPatch's 720 hours, this pissed off existing ActiPatch customers that could have migrated to the Wave
* BIEL pulled KT's exclusive US rights due to not meeting order minimums, KT has done a shift, now selling a 720 hour Wave in UK Boots stores
* BIEL had its highest revenue years selling ActiPatch at Boots stores in 2015-2017
* The Wave is KT's product and BIEL has no say in how KT markets it, BIEL's only recourse was to revoke KT's exclusive rights in the US which they did
Must have caught the comprehension virus from Art
The title of my post was, "May come as a shock to you but business deals don't always play out as planned"
Companies like Microsoft, Sprint and AOL, with all of their lawyers and analysts, have had deals they love go south but you can't understand the failure of KT to market the Wave ?
BIEL fulfilled their end of the contract, manufacturing as many Wave devices as KT ordered, packaged to KT's specs and ready to place on a retail shelf.
KT's job was to sell the Wave. Pricing, Marketing, Distribution was all exclusively under KT's control.
Based on KT's many years of retail experience BIEL felt that they could be successful selling the Wave.
May come as a shock to you but business deals don't always play out as planned
AOL and Time Warner - 2 years into their merger they had lost $99 billion
Microsoft and Nokia - beginning as a Partnership evolving into an acquisition by MS in which they lost $7 billion
Sprint and Nextel - 3 years after acquiring a majority interest in Nextel Sprint had lost $30 billion
I have listed the KT issues previously but since you have comprehension problems here they are again:
* KT is an athlete brand ranging from professional to weekend warrior, younger demographic
* Actipatch has a customer base consisting largely of chronic pain patients, older demographic
* KT never marketed the Wave to chronic pain patients, a market which is many times larger than the athlete market
* KT priced the Wave at $34.95, $5 more than ActiPatch, and lowered the life to 250 hours, 470 hours less than ActiPatch's 720 hours, this pissed of existing ActiPatch customers that could have migrated to the Wave
* BIEL pulled KT's exclusive US rights due to not meeting order minimums, KT has done a shift, now selling a 720 hour Wave in UK Boots stores
* BIEL had its highest revenue years selling ActiPatch at Boots stores in 2015-2017
* The Wave is KT's product and BIEL has no say in how KT markets it, BIEL's only recourse was to revoke KT's exclusive rights in the US which they did
100 percent Miami, there is a lot of prep needed for entering any new market, especially one created by government legislation
Savy players will already be establishing contacts with the implementers of this new legislation.
This is a major opportunity to break through the AMA / Big Pharma Cartel that have controlled what pain relief options patients have available for the last 100 years.
Chris Fox, Executive Director of the Voices for Non-Opioid Choices Coalition, issued the following
statement in response to congressional passage of the NOPAIN Act:
"We applaud Congress for taking critical and meaningful action to prevent opioid addiction before it
starts by expanding access to safe, non-opioid options for acute pain. The NOPAIN Act is a proactive,
much-needed solution to combat the deadly effects of the opioid crisis that takes the lives of 220
Americans every day. By making safe, FDA-approved non-opioid pain management options more
accessible, Congress is allowing patients and families to work with their providers to have a choice in
how they manage their pain.”
“The Voices Coalition commends those Members in the U.S. House and Senate who championed the
NOPAIN Act and the patients, providers, family members, and other advocates who bravely raised their
voices and shared their personal stories to advocate for this legislation. The passage of this bill would
not have been possible without the support of those legislative champions and over 100 organizations
and thousands of advocates who make up the Voices for Non-Opioid Choices Coalition.”
Been saying same thing for 12 years and yet BIEL is still here
Those who bought the 'Sky is Falling' BS missed out on numerous BIEL runs.
The largest was Q4 of 2020 - February 2021. While ddls was screaming "Sell, Sell, Sell" BIEL moved from .0006 in October 2020 to .004 in January 2021.
In February 2021 BIEL peaked at .008 .
Says the guy heavily invested in crypto
BIEL should feel honored that crypto interests are concerned about competition from BIEL for new investors.